| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.1 |